Kusajili – Clinical trials directory

Result of your search per sponsor: Klaus Mross, PD Dr. med

Woman and Man Max 99 years
Klaus Mross, PD Dr. med Update Il y a 4 ans

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies The purpose of the study is to investigate safety and tolerability of repeated ascending oral doses of 4SC-205 in patients with advanced and incurable solid tumors or malignant lymphomas.

Country Germany
organs None
Specialty None

Closed trial

More information